Dr. Natalia Echeverri, (R) uses a swab to gather a sample from the nose of Sammy Carpenter, who said he is homeless, to test him for COVID-19 on April 17, 2020 in Miami, Florida.
Joe Raedle | Getty Images
An ambitious new plan to radically increase the number of coronavirus tests in the United States would see up to 30 million people screened each week and cost up to $100 billion to implement, a private foundation said Tuesday.
But that pricey effort for what one expert called "the largest public health testing in history" is necessary to stem the $300 billion to $400 billion in American economic losses each month as a result of the Covid-19 pandemic, the Rockefeller Foundation said.
It said the sooner coronavirus tests become much more widely available, the quicker the U.S. economy can start getting back to normal.
"We do have the capacity to do that, and we've got the resources to do that," said Dr. Michael Pellini, managing partner of health venture firm Section 32 and board member of the Personalized Medicine Coalition, who contributed to the foundation's new plan.
"Yes, it's ambitious, but at this point we've got to do it," Pellini said. "We have to fix testing in this country to enable our workforce to be deployed once again."
The plan comes amid calls by numerous experts and by CEOs to boost coronavirus testing to make sure businesses and social events can reopen safely without sparking second and third waves of virus outbreaks.
Amazon CEO Jeff Bezos, in a note to shareholders last week, wrote:Regular testing on a global scale, across all industries, would both help keep people safe and help get the economy back up and running."
Rockefeller Foundation President Dr. Rajiv Shah said: "We envision an America where everyone who needs a test can get one."
Rajiv Shah, president of The Rockefeller Foundation
Jason Alden | Bloomberg | Getty Images
"The Rockefeller Foundation believes that testing access is critical to scaling up our lives and economy," Shah said during a conference call with reporters Monday, when the total number of confirmed coronavirus cases reached more than 766,600, and the number of related fatalities approached 41,000.
He called the up-to-$100 billion cost of the effort "a modest investment," given the amount of monthly economic losses to the nation, as well as the societal costs related to the outbreak, which could end up increasing rates of suicides, alcoholism and domestic violence.
While the goal of the testing plan is to build a state-led national program, the foundation said funding for it likely can come from federal funds through agencies or grants.
The foundation itself is investing $15 million to help kick off the effort, which includes supporting cities that are among the first to adopt the plan's recommendations.
The Rockefeller Foundation,which is a major philanthropicdonorin areas including health and science, told CNBC last week that it had been in contact with the Trump administration, national groups of governors and mayors and leading American corporations as it prepared the recommendations.
The foundation's plan lays out a strategy for tripling, within the next eight weeks, the existing 1 million coronavirus test per week now being done by maximizing efficiencies in testing capacity.
After that, the foundation calls for multiplying those 3 million tests per week by at least 10 times to get to at least 30 million tests each week within the next six months.
Reaching that level will entail, among other things, removing regulatory barriers to approval for new point-of-care and home-test kits, and ensuring payments for labs performing the tests.
The Rockefeller plan says that more testing must be done to accurately capture the level of Covid-19 infections in the U.S.
"In Taiwan, there have been 132 tests conducted for every confirmed case. In Australia, the number is 62. In the United States, it is five," an executive summary of the plan notes.
"The unfortunate conclusion from this comparison is that the country's actual number of infections may be 15- to 20-times higher than the reported number of confirmed cases," the summary says.
"In short, the United States needs to increase the current level of 1 million tests per week by at least 10-fold and preferably 20-fold to adequately monitor the pandemic."
The plan notes that "given the commercial uncertainties inherent in this 10-fold increase in production" it is likely the federal government would need to activate the Defense Production Act to compel production of tests.
The plan calls for the creation of an Emergency Network for Covid-19 Testing to coordinate and underwrite the testing market with the use of leverage from public-private credit guarantees and other tools.
The second part of the plan envisions a paid Covid Community Healthcare Corps of 100,000 to 300,000 people to perform the high number of texts and conduct "contact tracing," or reaching out to individuals who have been around infected people and testing them as well.
The third part is a common data and digital platform to support the first two objectives by sharing "real-time analyses of resource allocations, disease tracing results and patient medical records."
New York University professor Paul Romer, who shared the 2018 Nobel Prize in economics, said the need for a huge increase in the number of coronavirus tests is driven not only by the need to stanch current economic losses but to prevent permanent damage to U.S. economic output when the country exits recession.
"Our future capacity to produce" is lower because of the economic cost of the pandemic "and it deteriorates with each month of delay," said Romer, who contributed to the Rockefeller Foundation's plan.
But Romer said the solution to the testing problem lies in the current system, which needs to be reorganized and incentivized financially to produce enough tests.
"We're really not constrained on the supply side, but we are constrained by what we're willing to pay," Romer said.
"We just need to pay people and let them have to option to provide these tests."
Romer made the analogy of the government saying that there needed to be 300 million soft drinks made one day.
No one would step up to make the drinks for free, he suggested, but they would be made if the government agreed to pay for them.
See the rest here:
Coronavirus: New plan would test 30 million per week and cost up to $100 billion, but 'we've got to do it' - CNBC
- Personalized medicine could transform healthcare - PMC - April 24th, 2025
- Genomic medicine and personalized treatment: a narrative review - April 24th, 2025
- Podcast: Ochre Bios Approach To Precision Medicine In Liver Treatment - insights.citeline.com - April 24th, 2025
- Reinforcement Learning in Personalized Medicine: A Comprehensive Review of Treatment Optimization Strategies - Cureus - April 24th, 2025
- Evolving Biomarkers: Charting the Future of Precision Medicine - MarketScale - April 24th, 2025
- Next Generation Tissue Biomarkers Market Size Report 2030 - Grand View Research - April 24th, 2025
- City of Hope Research on Artificial Intelligence (AI), Precision Medicine, Immunotherapies and Other Topics to be Presented at American Association of... - April 24th, 2025
- What the Newest mRNA Vaccines Could Do Beyond COVID - News-Medical - April 24th, 2025
- Opinion: Where public health ends and personalised medicine begins - Pulse+IT News - April 24th, 2025
- Crohns Disease Treatment Market to Reach $5.9 Billion by 2034, Driven by Biologics & Precision Medicine - Global Banking | Finance | Review - April 24th, 2025
- The Role of High Throughput Screening in Precision Medicine and Market Growth In New Report - WhaTech - April 24th, 2025
- Antiviral Chewing Gum May Prevent Flu and Herpes Transmission - Inside Precision Medicine - April 14th, 2025
- Wisconsin's role in the next advances in health care - BizTimes - April 14th, 2025
- The Future of Pulmonary Fibrosis Management: Precision Medicine, Biomarkers and AI - Managed Healthcare Executive - April 14th, 2025
- Leading Driver In The Jetrea Market 2025: Rise Of Personalized Medicine Fueling Growth - EIN News - March 9th, 2025
- Personalized Medicine Market Overview 2024-2025 & 2030: Oncology, Neurology, and Cardiology Lead Expansion, ext-Generation Sequencing and AI... - March 9th, 2025
- Innovations in core-shell nanoparticles advance drug delivery and precision medicine - Phys.org - March 9th, 2025
- Personalized Medicine: Motivation, Challenges and Progress - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - HealthLeaders Media - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - Fast Company - February 24th, 2025
- Artificial Intelligence (Ai) In Precision Medicine Market to See Robust Growth from USD 2.14 Billion to USD - EIN News - February 24th, 2025
- BMY: 3 Precision Medicine Stocks That Could Transform Healthcare - StockNews.com - February 24th, 2025
- Cracking Cancers Code: How Genetic Testing Is Changing the Treatment Game - geneonline - February 24th, 2025
- Curt Medeiros on Revolutionizing Precision Medicine and Scaling Ovation - Madrona Venture Group - January 6th, 2025
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022